The effects of DMARDs on neonates can vary. Potential risks include:
- Premature birth: Some studies suggest that certain DMARDs may increase the risk of preterm labor. - Low birth weight: There is a potential risk of low birth weight, especially with drugs that are contraindicated during pregnancy. - Congenital anomalies: Some DMARDs, particularly methotrexate, are associated with congenital anomalies if taken during pregnancy.
These risks necessitate close monitoring and a careful risk-benefit analysis by healthcare providers.
